Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam C Yopp

Showing results (61-70 of 176) with videos related to

Pageof 18
Sort By:
Targeted Oncology|August 21, 2019
Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical TrialAli A Mokdad, Hao Zhu, Muhammad S Beg, et al.
The American Journal of Gastroenterology|January 22, 2014
The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysisAmit G Singal, Hema Manjunath, Adam C Yopp, et al.
Case Reports in Surgery|August 18, 2012
Rare hepatic arterial anatomic variants in patients requiring pancreatoduodenectomy and review of the literatureSmita Ramanadham, Seth M Toomay, Adam C Yopp, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 18, 2003
CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potentialShuang Fu, Adam C Yopp, Xia Mao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
Therapeutic delays lead to worse survival among patients with hepatocellular carcinomaAmit G Singal, Akbar K Waljee, Nishant Patel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2004
TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursorsShuang Fu, Nan Zhang, Adam C Yopp, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 21, 2012
Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infectionAdam C Yopp, Madhu Subramanian, Mamta K Jain, et al.
Clinical Imaging|July 14, 2020
Comparison of radiofrequency and microwave ablation and identification of risk factors for primary treatment failure and local progressionJoseph L McDevitt, Michael D Collard, Ryan P Murphy, et al.
Cancer|October 27, 2017
Effect of hospital safety net designation on treatment use and survival in hepatocellular carcinomaAli A Mokdad, Caitlin C Murphy, Sandi L Pruitt, et al.
The Journal of Surgical Research|March 12, 2019
Current Pattern of Use and Impact of Pringle Maneuver in Liver Resections in the United StatesCaitlin A Hester, Ali El Mokdad, John C Mansour, et al.
Pageof 18

Showing results (61-70 of 176) with videos related to

Sort By:
Pageof 18
Targeted Oncology|August 21, 2019
Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical TrialAli A Mokdad, Hao Zhu, Muhammad S Beg, et al.
The American Journal of Gastroenterology|January 22, 2014
The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysisAmit G Singal, Hema Manjunath, Adam C Yopp, et al.
Case Reports in Surgery|August 18, 2012
Rare hepatic arterial anatomic variants in patients requiring pancreatoduodenectomy and review of the literatureSmita Ramanadham, Seth M Toomay, Adam C Yopp, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 18, 2003
CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potentialShuang Fu, Adam C Yopp, Xia Mao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
Therapeutic delays lead to worse survival among patients with hepatocellular carcinomaAmit G Singal, Akbar K Waljee, Nishant Patel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2004
TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursorsShuang Fu, Nan Zhang, Adam C Yopp, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 21, 2012
Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infectionAdam C Yopp, Madhu Subramanian, Mamta K Jain, et al.
Clinical Imaging|July 14, 2020
Comparison of radiofrequency and microwave ablation and identification of risk factors for primary treatment failure and local progressionJoseph L McDevitt, Michael D Collard, Ryan P Murphy, et al.
Cancer|October 27, 2017
Effect of hospital safety net designation on treatment use and survival in hepatocellular carcinomaAli A Mokdad, Caitlin C Murphy, Sandi L Pruitt, et al.
The Journal of Surgical Research|March 12, 2019
Current Pattern of Use and Impact of Pringle Maneuver in Liver Resections in the United StatesCaitlin A Hester, Ali El Mokdad, John C Mansour, et al.
Pageof 18